Effect of calponin and 38 kD actin-binding proteolytic fragment of caldesmon on actin structure alterations, initiated by decoration of thin filaments by N-ethylmaleimide-modified skeletal myosin subfragment-1 (NEM-S1) and by phosphorylated smooth heavy meromyosin (pHMM), has been studied by polarized fluorimetry. F-actin of myosin-free ghost fiber was labeled with fluorescent probe fluoroscein-5-maleimide. Both the actin-binding regulatory proteins have been demonstrated to inhibit conformational changes of actin typical for the "strong" binding of myosin head to actin. Tropomyosin weakens the inhibitory effect of calponin and markedly increases the effect of the 38 kD fragment of caldesmon. The results indicate similarity of molecular mechanisms of the regulation of muscle contraction by calponin and the actin-binding fragment of caldesmon. It is proposed that the regulation of smooth muscle contraction by calponin and caldesmon is carried out via the inhibition of the formation of the stage AM in ATP hydrolysis cycle.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fragment caldesmon
12
binding myosin
8
calponin actin-binding
8
muscle contraction
8
contraction calponin
8
calponin
5
[the caldesmon
4
fragment
4
caldesmon fragment
4
fragment mol
4

Similar Publications

Inflammatory leiomyosarcoma (ILMS) is a rare malignant soft tissue neoplasm with smooth muscle differentiation, prominent inflammatory infiltration, and near-haploidization. It is extremely rare in the head and neck region, and no intraoral cases have been reported. The lesion was initially diagnosed as a malignant spindle cell neoplasm at the referring laboratory.

View Article and Find Full Text PDF

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

Alzheimers Dement

September 2024

Department of Psychiatry and Neuropsychology, Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Article Synopsis
  • The study investigated the role of neurodegeneration markers (neurogranin, neurofilament light, and hippocampal volume) in Alzheimer's disease using cerebrospinal fluid proteomics.
  • A small number of individuals exhibited both amyloid and tau pathology with either neurogranin or neurofilament light, showing distinct proteomic profiles based on these markers.
  • The findings suggest that neurogranin might not be the best indicator of neurodegeneration and that different markers provide unique insights into the disease, helping refine staging beyond just amyloid and tau levels.
View Article and Find Full Text PDF

Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.

Neurobiol Aging

September 2024

Amsterdam Neuroscience, Neurodegeneration, De Boelelaan 1085, Amsterdam 1081 HV, the Netherlands; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, Amsterdam 1081 HV, the Netherlands; Neurochemistry Laboratory, Department of Laboratory Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1117, Amsterdam 1081 HV, the Netherlands.

Article Synopsis
  • The study investigates the relationship between traumatic brain injury (TBI) and Alzheimer's disease (AD) by comparing AD patients with and without a history of TBI, focusing on various biomarkers in their cerebrospinal fluid (CSF).
  • Researchers found no significant differences in baseline CSF biomarker levels or cognitive decline between the two groups of AD patients, suggesting that TBI may not directly affect AD progression.
  • However, TBI occurring more than five years prior was linked to higher levels of specific biomarkers (NPTX2 and a trend for SNAP25), indicating possible long-term synaptic dysfunction effects when TBI occurs before the onset of AD.
View Article and Find Full Text PDF
Article Synopsis
  • Regulation of neurotransmitter release is crucial for different types of information processing in the brain, with Munc13 proteins being key players in this process.
  • Munc13-1 has specific domains, including a calmodulin binding (CaMb) domain for short-term plasticity and a CA domain that dimerizes and interacts with other proteins influencing presynaptic activity.
  • Research indicates that the Munc13-1's activity is inhibited by interactions between its domains but can be enhanced by other proteins like RIM2α and calmodulin, highlighting a complex mechanism of regulating neurotransmitter release.
View Article and Find Full Text PDF

Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as novel therapeutics to treat diabetic kidney disease (DKD). Although the beneficial effects of SGLT2i have been demonstrated, their target mechanisms on kidney function are unknown. The current study aimed to elucidate these mechanisms by studying SGLT2i-induced changes in the urinary proteome of persons with type 2 diabetes (T2D) and DKD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!